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ABSTRACT 
Epidemiology of NSAIDs gastropathy is increasing as 
increase number of usage. From arthritis to cardiovascular 
events and cancer prevention, the versatility of NSAIDs is not 
questioned. However, no dose of NSAIDs is safe. No matter low 
dose, or single use, NSAIDs will cause gastric damage upto 3-7 
days after use. In inflammation and healing process of 
gastropathy there were various proteins involved, but treatment 
with COX-2 and SRF were associated with an immediate healing 
and better quality of gastric mucosa. Cyclea barbata (miers.) 
has been declared as a functional food for preventing and 
treatment gastropathy yet, its mechanism of actions have not 
yet clearly discovered. Hence the aim of this study is to analyze 
the effects of Cyclea barbata (miers.) ethanol extract to COX-2 
and SRF in gastric tissue, in time series basis. Laboratory mice 
were induced with aspirin to produce gastropathy and then 
treated with Cyclea barbata (miers.) extract for 1, 3, 7, 10 or 14 
days. Gastric tissue then harvested and analysed with elisa 
procedure to determine tissue SRF and COX-2 level. Treatment 
was proven to increase COX-2 and SRF higher than the control 
group. This concludes one of Cyclea barbata (miers.) mechanism 
for NSAIDs gastropathy is by increasing tissue COX-2 and SRF.  
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INTRODUCTION 
Aspirin though well known for its 
gastrointestinal side effects, remains the most 
common used drug. Many prevention and 
treatment options were available for aspirin 
induced gastropathy (Brown et al., 2006; 
Melcarne et al., 2016). Natural remedies have 
been researched and proven to have protective 
and therapeutic effects due to their active 
ingredients, i.e polyphenols and flavonoids 
(Farzaei et al., 2015; Simon and Evan 2017).  
Natural remedy commonly used is Cyclea 
barbata (miers.) leaves. It has been used across 
south east Asia region as refreshing drinks and 
natural remedies for stomachache and fever 
dated since the 1980s (Trimurtini 2015; 
Verpoorte et al., 1982). Further researches of 
Cyclea barbata (miers.) shown several properties 
ie: antibacterial (Permanasari, 2015), anti-
oxidant (Shodiq Ali Muhammad, 2012), anti-
cancer (Alam et al., 2016) and an effective 
therapy for NSAID induced peptic ulcer that is 
as leaast equal to misoprostol (Trimurtini, 
2007). Those properties were gained from their 
active contents, namely: polyphenol, tannin, 
flavonoid, (DL)-proto-quersitol, bis-benzyl-
isoquinoline alkaloid, calcium, phosphor, 
vitamin A and B (Permanasari, 2015).  
Ingestion of flavonoids through diet or 
as pure compounds can be trace in the 
gastrointestinal tract for a period of time,  
hence considered as first putative target of 
flavonoid. Flavonoids effect on gastric mucosa 
involves blockade of acid secretion, direct 
prostaglandin E2-dependent and antioxidative 
action by chelating ROS. Flavonoids may also 
reduce intestinal motility and secretion to 
reducing chronic inflammatory injury (Samara, 
2009). 
COX-2 is the culprit of many 
inflammation disease and understood that 
inhibiting COX-2 would bring healing, sadly 
that is a giant misconception. As COX-2 is the 
one stimulate growth factor production and 
epithelial proliferation that were important in 
ulcer healing (Tarnawski, 2012).  
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Serum Response Factor (SRF) is a 
transcription factor that plays equally important 
roles in healing and the cell phenotypic 
modulator. SRF acts as a central regulator of 
genes involved in apoptosis, dedifferentiation, 
proliferation, and migration of cells (Ro and 
Words 2016). Gastric injury activates SRF 
expression in the epithelial cells lining ulcer 
margin and regenerating glands; and in 
myofibroblasts and smooth muscle cells of 
granulation tissue (Chai, 2004). Healing process 
involves four main processes ie homeostasis, 
inflammation, proliferation and glands 
reconstruction, COX-2 is involved in 
inflammation and SRF is involved in all four. 
This study interest is in finding the role of 
Cyclea barbata (miers.) extract in the healing 
process of NSAIDs gastropathy and an effort 
to establish a time line of COX-2 and SRF 
gastric tissue concentration.  
 
MATERIAL AND METHOD 
Extract Preparation 
Three kg of Cyclea barbata (miers.) leaves 
harvested on January 2017 (Kediri area). Fresh 
leaves were washed and dried with open air for 
about 1 week. The extraction procedure was 
done in Materia medica, Batu. The procedures 
were grounding dried leaves and sifting with 
0.125mm sifter resulting 300g fine powder. 
Powder mixed with 3000mL 70% ethanol 
(1:10) and macerated for 5 days in room 
temperature and thickened with a rotary 
evaporator in 50°C resulting final product of 
195mL of thick extract. Extract then diluted 
with distilled water to get 50mg/mL solution.  
 
Polyphenol content determination 
The procedure was done in Testing Unit, 
Faculty of Pharmacy, University of Airlangga. 
Results show polyphenol in extract was 
1.14±0.02% B/B   
 
Animals  
40 male laboratory mouse (Mus musculus) 
strain Balb/c were used, obtained from the 
center of veterinary pharmacy Surabaya, the 
weight range of 25-35g, placed under controlled 
conditions (room temperature kept 28-32°C, 
and 12-12h light-dark cycle). Diet and water 
provided  ad libitum.   Experimental procedures  
were approved by the Health Research Ethical 
Clearance Commision (HRECC) from Faculty of 
Dentistry Univeristy of Airlangga. 
 
NSAIDs gastropathy induction 
procedure 
Aspirin (Bayer) diluted with distilled 
water to make a solution of 50mg/mL. All 
animals were fasted from food for 24h before 
induction by oral gavage 2x200mg/kg BW for 1 
day. After induction, animals were randomly 
divided into 10 groups of 4 mouse. 
 
Research procedure 
Groups of the mouse were number         
K1-K10. Groups were paired by two K1-K2 
(treatment for 1 day), K3-K4 (treatment 3 
days), K5-K6 (treatment for 7 days), K7-K8 
(treatment for 10 days), K9-K10 (treatment for 
14 days). Odd groups were control group 
receiving distilled water and even numbered 
group were treatment, receiving once a day 
40.5mg/kg BW Cyclea barbata (miers.) ethanol 
extract.  
After completed treatment, subjects were 
fasted for 12h and terminated, the abdomen 
was opened, stomach organ located, cut open 
along the greater curvature and cleaned with 
phosphate buffer solution pH 7.4. After general 
examination for hemorrhage and ulcer, tissue 
harvested were prepared for elisa procedure in 
Leprosy laboratory in Tropical Disease Centre, 
University of Airlangga, with COX-2 and SRF 
kit (bioassay).  
 
RESULTS AND DISCUSSION 
The results of COX-2 and SRF were 
shown (Table I and II) respectively. In day 1, 
there is no diffrence between control and 
treatment groups, might be because treatment 
has not interfered COX-2 nor SRF synthesis.  
 
Table I. Gastric tissue COX-2 (ng/mL) 
 
Day Control Treatment P-value 
1 0.0220 0.02825 0.08976 
3 0.0728 0.04675 0.01327 
7 0.0690 0.1045 0.00086 
10 0.0605 0.0625 0.7282 
14 0.0523 0.05475 0.3911 
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Table II. Gastric tissue SRF (ng/L) 
 
Day Control Treatment P value 
1 0.0220 0.02825 0.8376 
3 0.0728 0.04675 0.04311 
7 0.0690 0.1045 0.01187 
10 0.0605 0.0625 0.1047 
14 0.0523 0.05475 0.00051 
 
COX-2  
On day 3, control group has higher 
results than treatment, this proves that one time 
induction of NSAIDS can cause gastropathy 
stimulating the production of tissue COX-2 
and keep progressing until day 3-7 (Soylu et al., 
2008). Treatment group COX-2 on this day is 
lower than control might be due to Cyclea 
barbata (miers.) ROS chelating effect and activate 
gastroprotection (Lucena Périco et al., 2015), 
hence delay gastropathy progression and 
causing delayed in COX-2 concentration peak 
up to day 7. This research also shows that in 
day 7, treatment group has 30% higher results 
than control and 100% increase from treatment 
group from day 3. This surge shows that active 
chemical content from the ethanol extract of 
Cyclea barbata (miers.) does have gastroprotective 
activity, and improve healing, hence can be said 
have a therapeutic effect in gastropathy. 
COX-2 in both groups was shown 
increasing tough aspirin is an irreversible and 
unselective COX inhibitor. Therefore can be 
concluded increasing amount of COX-2 is by 
newly synthetized. Day 10 marks the start of 
proliferation stage of wound healing (Wietecha, 
2015). Both control and treatment group 
experience decreasing the level of COX-2 on 
day 10 and 14 suggesting no more stimuli to 
provoke inflammation in the gastric area, 
suggesting acute inflammation is over and the 
disease progressed to a resolution of 
inflammation (Wallace, 2006). The drastric 
drop of COX-2 from treatment group shows 
intake of Cyclea barbata (miers.) extract induces 
resolution of inflammation, hence cutting 
inflammation time and induce faster healing 
process. The increased COX-2 in the tissue will 
convert arachidonic acid to prostaglandin 
(PGE2), and it will increase mitotic rate, a 
number of surfaces epithelial and mucosal 
foveolar cells, hence its mucus production and 
tissue mucosa layer thickness (Wallace, 2006). 
 
 
Figure 1. Graph of gastric tissue COX-2 
concentration by time. 
 
SRF 
The role of SRF in mucosal healing 
comprise from hemostasis process by affecting 
megakaryocyte maturation hence controling 
platelet formation and function; inflammation 
prosess by inducing neutrophil migration; 
proliferation and glands reconstruction by 
activating immediate early genes and 
cytoskeletal genes, that in turn will trigger 
proliferation of smooth muscle cells and 
fibroblasts; differentiation of fibroblasts into 
myofibroblasts; pro-inflammatory regulators 
(e.g: interleukin-1α, interleukin-6, and COX-2); 
and angiogenic factor genes (i.e.: bFGF and 
vascular endothelial growth factor (VEGF)) 
(Tarnawski and Ahluwalia, 2012; Taylor et al., 
2014).  
SRF in treatment group consistently 
higher than control group since day 1 of 
treatment, and reaches its peak on day 14, 
indicating both groups were experiencing injury 
and undergo healing process and SRF is 
naturally increased in response to mucosal 
injury. After aspirin induction, gastropathy 
produced will cause tissue capiller haemorage, 
and blood serum leaked activated SRF. During 
inflammation process, growth factors, 
cytokines, and other mitogenic stimuli will 
further stimulate SRF production, consequently 
increasing SRF tissue level even higher as 
disease progress. 
Tough COX-2 in control group reached 
peak concentration on day 3, control group 
SRF in day 3 (K3) has not shown significant 
different with treatment group but linier to 
previous research that increase of SRF starting 
on day 3 (Tarnawski, 2012). On day 7, SRF in 
the treatment group is 20% higher compared to 
controlled showing SRF role in cellular repair 
and fibroblast formation needed for tissue 
repair (Chen, 2016). This proves though 
pathway is not cleared, Cyclea barbata (miers.) 
ethanol extract has effects to the molecular 
Ethanol Extract of Cyclea barbata (Miers.) 
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level. On day 14 control group, though there is 
a slight decrease, the level is still high showing 
on going healing process but in reduced pace. 
In treatment group however, the concentration 
increases meaning healing process continued. 
This will result in faster gland reconstruction, 
better ulcer healing quality and reducing the 
probability of gastropathy or re-bleeding in the 
same site (Arakawa et al., 2012; Kangwan, et al., 
(Figure 2). 
 
 
 
Figure 2. Graph of gastric tissue SRF 
concentration by time. 
 
CONCLUSION  
The increase of both COX-2 and SRF 
concentration shows Cyclea barbata (miers.) 
ethanol extract is useful in the treatment of 
NSAIDs gastropahty, specially aspirin induced 
gastropathy. Diseases progression was delayed 
on early days but then COX-2 was increased to 
a level where it triggers inflammation needed 
for healing but not excessive that causes 
chronic inflammatory diseases. It subsided 
starting on day 7 to promote resolution of 
inflammation and healing proven by SRF level 
constantly increasing as SRF needed to induce 
dedifferentiation, proliferation, and migration 
of cells. Hence it is concluded that Cyclea 
barbata (miers.) is a potent anti oxidant and an 
inflammation modulator.  
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